Form 8.3 - [AbbVie Inc.]
March 18 2020 - 10:36AM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 17(th) March 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 68,013,335 4.58786%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 68,013,335 4.58786%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 4,687 70.45
-------------- ----------------------------- -----------------------
Purchase 6,048 70.45
-------------- ----------------------------- -----------------------
Purchase 13,564 70.45
-------------- ----------------------------- -----------------------
Purchase 1,600 73.02
-------------- ----------------------------- -----------------------
Purchase 6,200 73.02
-------------- ----------------------------- -----------------------
Purchase 700 73.02
-------------- ----------------------------- -----------------------
Purchase 1,300 73.02
-------------- ----------------------------- -----------------------
Purchase 7,532 70.45
-------------- ----------------------------- -----------------------
Purchase 200 73.02
-------------- ----------------------------- -----------------------
Purchase 900 73.02
-------------- ----------------------------- -----------------------
Purchase 3,520 70.45
-------------- ----------------------------- -----------------------
Purchase 25,781 73.02
-------------- ----------------------------- -----------------------
Purchase 7,980 73.02
-------------- ----------------------------- -----------------------
Purchase 1,600 74.59
-------------- ----------------------------- -----------------------
Purchase 13,188 73.02
-------------- ----------------------------- -----------------------
Purchase 1,263 73.02
-------------- ----------------------------- -----------------------
Purchase 225 73.02
-------------- ----------------------------- -----------------------
Purchase 68 70.45
-------------- ----------------------------- -----------------------
Purchase 500 73.02
-------------- ----------------------------- -----------------------
Purchase 59 73.02
-------------- ----------------------------- -----------------------
Purchase 5,369 70.45
-------------- ----------------------------- -----------------------
Purchase 1,412 74.40
-------------- ----------------------------- -----------------------
Purchase 413 73.02
-------------- ----------------------------- -----------------------
Purchase 2,931 73.02
-------------- ----------------------------- -----------------------
Purchase 1,614 73.02
-------------- ----------------------------- -----------------------
Sale 400 73.02
-------------- ----------------------------- -----------------------
Sale 300 73.02
-------------- ----------------------------- -----------------------
Sale 500 75.40
-------------- ----------------------------- -----------------------
Sale 5,600 73.08
-------------- ----------------------------- -----------------------
Sale 2,900 73.02
-------------- ----------------------------- -----------------------
Sale 200 73.02
-------------- ----------------------------- -----------------------
Sale 500 73.02
-------------- ----------------------------- -----------------------
Sale 3,600 73.02
-------------- ----------------------------- -----------------------
Sale 1,600 73.02
-------------- ----------------------------- -----------------------
Sale 900 73.02
-------------- ----------------------------- -----------------------
Sale 1,300 73.02
-------------- ----------------------------- -----------------------
Sale 6,200 73.02
-------------- ----------------------------- -----------------------
Sale 19 72.86
-------------- ----------------------------- -----------------------
Sale 312 73.02
-------------- ----------------------------- -----------------------
Sale 1,788 73.02
-------------- ----------------------------- -----------------------
Sale 485,394 73.02
-------------- ----------------------------- -----------------------
Sale 2,900 73.02
-------------- ----------------------------- -----------------------
Sale 3,880 73.02
-------------- ----------------------------- -----------------------
Sale 2,222 73.02
-------------- ----------------------------- -----------------------
Sale 72,534 73.02
-------------- ----------------------------- -----------------------
Sale 735 73.02
-------------- ----------------------------- -----------------------
Sale 22,734 73.02
-------------- ----------------------------- -----------------------
Sale 600 75.41
-------------- ----------------------------- -----------------------
Sale 5,862 73.02
-------------- ----------------------------- -----------------------
Sale 269 73.02
-------------- ----------------------------- -----------------------
Sale 569 73.02
-------------- ----------------------------- -----------------------
Sale 9,387 73.02
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 18(th) March 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 18, 2020 10:21 ET (14:21 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Sep 2023 to Sep 2024
